Suppr超能文献

异丙肾上腺素诱导心肌肥大过程中的蛋白质代谢研究。

Studies on protein metabolism during isoproterenol-induced cardiac hypertrophy.

作者信息

Deshaies Y, LeBlanc J, Willemot J

出版信息

Recent Adv Stud Cardiac Struct Metab. 1975;8:387-95.

PMID:129835
Abstract

Chronic treatment with isoproterenol (ISO) (30 mug/100 g body wt/day for 21 days) causes a hypertrophy of the heart (approximately 40%). Protein determination made on homogenates of the heart show similar percentages of protein in the control and treated animals. Thus, ISO presumably stimulates protein synthesis in the heart, as its total protein content is increased by chronic treatment. Studies of the stimulation of protein synthesis during a 9-day treatment with ISO have been carried out by following the incorporation of 14C-labeled amino acids in vivo into heart protein. This stimulation attained a maximum after 5 days of treatment and then declined. In other experiments, groups of rats received a single injection of ISO and were killed at various times (from 0 to 48 hr) after the injection. Stimulation of protein synthesis was maximal 3 hr after the injection, and it slowly decreased until the 36th hr. After that time the rate of protein synthesis was equal to that of control animals. Other groups of rats received daily injections of ISO for 9 days and were killed at various times after the ninth injection. Protein synthesis was still stimulated by ISO; however, the stimulation was observed only during the first 12 hr following the injection of the 9th day. There was an apparent inhibition of protein synthesis which lasted from the 30th to the 48th hr following the ninth injection. The rate of protein degradation did not seem to be affected by a chronic treatment with ISO. Thus, the increased rate of protein synthesis seems to be the sole factor responsible for the increase of the total protein content of the heart, even if the stimulation of the incorporation of labeled amino acids decreased after a few days of treatment.

摘要

用异丙肾上腺素(ISO)进行慢性治疗(30微克/100克体重/天,持续21天)会导致心脏肥大(约40%)。对心脏匀浆进行的蛋白质测定显示,对照动物和治疗动物的蛋白质百分比相似。因此,ISO可能刺激心脏中的蛋白质合成,因为其总蛋白质含量通过慢性治疗而增加。通过追踪体内14C标记氨基酸掺入心脏蛋白质的情况,对ISO进行9天治疗期间蛋白质合成的刺激作用进行了研究。这种刺激在治疗5天后达到最大值,然后下降。在其他实验中,给大鼠组单次注射ISO,并在注射后不同时间(0至48小时)处死。注射后3小时蛋白质合成刺激作用最大,然后缓慢下降直至36小时。此后,蛋白质合成速率与对照动物相等。其他大鼠组每天注射ISO,共9天,并在第9次注射后的不同时间处死。ISO仍能刺激蛋白质合成;然而,仅在第9天注射后的前12小时观察到这种刺激作用。在第9次注射后的第30至48小时,蛋白质合成出现明显抑制。蛋白质降解速率似乎不受ISO慢性治疗的影响。因此,蛋白质合成速率的增加似乎是心脏总蛋白质含量增加的唯一原因,即使在治疗几天后标记氨基酸掺入的刺激作用下降。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验